Senior Research Fellow

Collins McNicholas Recruitment; Dublin; On-site; EUR 60,000 - 80,000; Full time

Job summary

A reputable recruitment agency is looking for a Senior Research Fellow in Dublin. This role involves leading high-impact translational research on dual-cell therapy for neonatal brain injury. The ideal candidate will have a PhD and 4+ years of post-PhD experience, demonstrated leadership, and expertise in cell biology and omics technologies. This position offers a competitive salary, flexible working, and developmental support.

Benefits

Pension

Private Health Insurance

Income Protection

25 days annual leave

Flexible working

Career development support

Qualifications

• 4+ years post-PhD experience in relevant research areas.
• Proven leadership with a strong publication record.
• Expertise in cell biology and neuronal/neurovascular models.
• Hands-on experience with omics technologies.

Responsibilities

• Design and validate in vitro models relevant to neonatal brain injury.
• Conduct proteomic and transcriptomic analyses.
• Integrate multi-omics data to identify therapeutic pathways.
• Lead a multidisciplinary team and mentor junior researchers.

Skills

Leadership

Project Management

Communication

Data Analysis

Cell Biology

Omics Technologies

Education

PhD in Neuroscience, Cell Therapy, Regenerative Medicine, Biotechnology or a related field

Job description

We have a new opportunity for Senior Research Fellow with our client based in Dublin.

Location: Dublin, Ireland

Contract: 30-Month Fixed Term

Salary & Benefits: Competitive package including pension, private health insurance, income protection, 25 days annual leave (plus additional company days), flexible working, and strong career development support.

Role Overview

We are seeking a Senior Research Fellow to join a multidisciplinary consortium focused on advancing a dual-cell therapy for neonatal hypoxia-associated brain injury. This is a high-impact translational research role, supporting the transition from preclinical development toward First-In-Human, Phase 1 clinical trials.

The role offers the opportunity to lead analytical development, explore critical quality attributes (CQAs), and develop potency matrices while driving innovative research in neurovascular injury models.

Key Responsibilities

• Design, optimize, and validate in vitro hypoxia and neurovascular models relevant to neonatal brain injury.
• Conduct proteomic and transcriptomic analyses (RNA-seq) to study mechanisms of action for MSC and ECFC co-therapy.
• Integrate multi-omics data to identify therapeutic pathways and biomarkers.
• Define and monitor CQAs (identity, purity, viability, immunophenotype) and develop potency assays.
• Develop release assays ensuring product consistency and regulatory compliance.
• Lead a multidisciplinary team, managing project milestones, deliverables, and data quality.
• Mentor junior researchers and PhD students.
• Prepare manuscripts, grant reports, and contribute to regulatory submissions.
• Present findings at scientific conferences, consortium meetings, and stakeholder briefings.

Essential Criteria

• PhD in Neuroscience, Cell Therapy, Regenerative Medicine, Biotechnology, or a related field.
• 4+ years post-PhD experience in relevant research areas.
• Proven leadership with a strong publication record, international conference presentations, and supervision of junior staff/PhD students.
• Expertise in cell biology (MSCs, ECFCs) and neuronal/neurovascular models.
• Hands‑on experience with omics technologies (proteomics, transcriptomics) and data analysis.
• Experience in defining CQAs, potency assays, and ATMP release criteria.
• Familiarity with regulatory frameworks for ATMPs and translational research toward clinical trials.
• Strong project management, analytical, and communication skills.

For further details on this opportunity, please reach out to Gillian Nicholson to [e-mail]